Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Heather Lockyer"'
Autor:
Tyler Nielsen, Rob Seitz, Douglas Ross, David Hout, Brock Schweitzer, David Gandara, David Saltman, Nicole Croteau, Heather Lockyer, Frank McMahon, Jeremy Spille, Andrea Dickey, Matthew Varga, Kim McGregor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e817bad23cf54eeb8bc4dce9c0f11e9e
Autor:
David Saltman, Nicole Croteau, Heather Lockyer, Rob Seitz, Frank McMahon, Jeremy Spille, Andrea Dickey, Jordan Jennings, Matthew Varga, Kimberly McGregor, Tyler Nielsen, David Hout, Brock Schweitzer, Douglas Ross, David Gandara
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f962c0f2c690751ffc8cbbfef92483f
https://doi.org/10.1136/jitc-2022-sitc2022.0059
https://doi.org/10.1136/jitc-2022-sitc2022.0059
Autor:
David Saltman, Rob Seitz, Tyler Nielsen, Matthew Varga, Nicole Croteau, Heather Lockyer, David Hout, Brock Schweitzer, Douglas Ross, Amit Jain, Gregory Vidal, David Gandara
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fad8a2add7080131968ae7120d0f53c
https://doi.org/10.1136/jitc-2022-sitc2022.0101
https://doi.org/10.1136/jitc-2022-sitc2022.0101
Autor:
Douglas T. Ross, Andrea Dickey, Frank McMahon, Nicole S. Croteau, David R. Gandara, Kim McGregor, Rob Seitz, David L. Saltman, Tyler J. Nielsen, David R. Hout, Jeremy Spille, Heather Lockyer, Brock L. Schweitzer, Matthew Varga
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundLung cancer is the leading cause of cancer-related deaths worldwide. The advent of ICIs specifically targeting programmed cell death protein-1 (PD-1), or its ligand (PD-L1) represents a major therapeutic advance that is now included in stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7807f024395ed6dea09b51f4836e2c25
https://doaj.org/article/e817bad23cf54eeb8bc4dce9c0f11e9e
https://doaj.org/article/e817bad23cf54eeb8bc4dce9c0f11e9e
Publikováno v:
Journal of Clinical Oncology. 40:290-290
290 Background: Ovarian cancer (OC) is a common, often fatal disease where 1/4 of cases are due to hereditary syndromes. Genetic screening of OC patients provides access to targeted treatments and screening recommendations. Patients are currently ref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dcea50bacc74918b3af5e5a6fc78f87
https://doi.org/10.1200/jco.2022.40.28_suppl.290
https://doi.org/10.1200/jco.2022.40.28_suppl.290